News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Genetic markers being used to target oral hepatitis C drug

Please note embargo:

Pharmac_P540c

Genetic markers being used to target new oral hepatitis C drug

A person’s genetic makeup will be used to target a new funded oral treatment for hepatitis C patients from 1 September.

PHARMAC will begin funding boceprevir (Victrelis) from 1 September 2013 for certain patients with the chronic liver infection. Boceprevir will be funded when used as a triple therapy in combination with pegylated interferon with ribavirin.

PHARMAC Medical Director Dr Peter Moodie says many hepatitis C patients do not respond well to current treatments, but that this could improve with the addition of boceprevir.

“Clinical evidence shows that, given the genetic characteristics of a patient, a simple genetic test can fairly accurately predict how they might respond to treatment,” says Dr Moodie.

“There is a group who we know respond poorly to current treatment. They are the ones we think will benefit most from the addition of this new treatment.”

About 25-35% of patients with certain genes showed a sustained response to the currently available treatment of pegylated interferon and ribavirin. By adding boceprevir to the treatment of these patients, the response rate increases to 70–75%.

As well as adding greater effectiveness to available treatments, Dr Moodie says boceprevir is the first funded oral treatment specifically for hepatitis C.

Patients will be genetically tested to determine whether they qualify for boceprevir (in combination with pegylated interferon and ribavirin) as a first-line treatment.

Boceprevir will also be funded for people who have tried but not responded completely to a course of pegylated interferon and ribavirin.

Dr Moodie says though many people live with hepatitis C without ever knowing it, the infection can cause significant health issues including hepatocellular carcinoma, liver failure, which may require a liver transplant.

Pharmacological treatment aims to reduce the likelihood of these transplants being required. In total, PHARMAC expects around 300 patients to start triple therapy in the next year.

In addition to funding boceprevir, PHARMAC has negotiated a price reduction for the Pegasys brand of pegylated interferon with ribavirin. Together, the funding of these hepatitis C treatments will cost $17.8 million over five years, with some of this cost being refunded through confidential rebates negotiated with both suppliers.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Flagging Enthusiasm: Gareth Morgan Announces Winner Of $20k Flag Competition

The winner of the Morgan Foundation’s $20,000 flag competition is “Wā kāinga / Home”, designed by Auckland based Studio Alexander. Economist and philanthropist Gareth Morgan set up the competition because he had strong views on what the flag should represent but he couldn’t draw one himself. More>>

ALSO:

Books: The Lawson Quins Tell Their Incredible Story

They could have been any family of six children – except that five of them were born at once. It will come as a shock to many older New Zealanders to realise that Saturday July 25 is the Lawson quintuplets’ 50th birthday. More>>

Scoop Review Of Books: Wartime Women

Coinciding as it does with the movie Imitation Game which focusses on Alan Turing breaking the Enigma code in Hut 6 at Bletchley Park (“BP”), this book is likely to attract a wide readership. It deserves to do so, as it illustrates that BP was very much more than Turing and his colleagues. More>>

Maori Language Commission: Te Wiki O Te Reo Māori 2015

The theme for Māori Language Week 27 July – 2 August 2015 is ‘Whāngaihia te Reo ki ngā Mātua’ ‘Nurture the language in parents’. It aims to encourage and support every day Māori language use for parents and caregivers with children” says Acting Chief Executive Tuehu Harris.. More>>

ALSO:

Live Music: Earl Sweatshirt Plays To Sold Out Bodega

The hyped sell-out crowd had already packed themselves as close as they could get to the stage before Earl came on. The smell of weed, sweat and beer filled Bodega – more debauched sauna than bar by this point. When he arrived on stage the screaming ... More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news